Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152949 Phosphatases
08/14/2003US20030152946 Bh4-fused polypeptides
08/14/2003US20030152941 Nucleic acids encoding novel von Willebrand/Thrombospondin factor-like polypeptides and uses of same
08/14/2003US20030152940 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography
08/14/2003US20030152939 Novel secreted proteins and polynucleotides encoding them
08/14/2003US20030152935 Comprises hybridization probes; electrophoresis; drug screening
08/14/2003US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152615 Enhanced drug delivery in transdermal systems
08/14/2003US20030152614 Enhanced drug delivery in transdermal systems
08/14/2003US20030152613 Steroid on carrier containing pressure sensitive adhesive
08/14/2003US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses
08/14/2003US20030152596 Mixture of elastase inhibitor and fungicide or bactericide; antiinflammatory agent
08/14/2003US20030152593 Polypeptide; suppress cattle leukemia
08/14/2003US20030152590 Virion protein; induce immunology response; genetic engineered Dna
08/14/2003US20030152583 Dna which codes complex
08/14/2003US20030152581 Compound and method for the prevention and/or the treatment of allergy
08/14/2003US20030152580 Induce immunology response; viricides, anticancer agents
08/14/2003US20030152576 Antiinflammatory agents; hepatitis virus; vaccines
08/14/2003US20030152574 Modulate nucleic acid gene expression
08/14/2003US20030152573 Anticancer, antitumor agents
08/14/2003US20030152572 Blocking production of synoviocytes; antiinflammatory agents; prevent signal transduction
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152567 Protease for activating clotting factor VII
08/14/2003US20030152566 Soluble CD40L (CD154) as a prognostic marker of atherosclerotic diseases
08/14/2003US20030152565 Pharmaceutical compositions containing proteins
08/14/2003US20030152564 Anti-inflammatory peptides derived from C-reactive protein
08/14/2003US20030152563 Administering plasminogen activator; biocompatiblity coupling to red blood carrier; drug delivery
08/14/2003US20030152560 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy
08/14/2003US20030152558 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
08/14/2003US20030152553 Transfection, transduction of cells
08/14/2003US20030152552 Synergistic mixture; viricides, antiproliferative agents, antiinflammatory agents; side effect reduction
08/14/2003US20030152551 2-Methyl-3-butenyl-1-pyrophosphoric acid salt and agent for treating lymphocytes
08/14/2003US20030152550 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
08/14/2003US20030152526 Bovine milk growth factor
08/14/2003US20030152522 System for delivering antiadhesion composition comprising canister containing composition, valve adapted to permit flow of antiadhesion composition therethrough, pressure source; surgery
08/14/2003CA2697599A1 Method of treating and preventing bone loss
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2475609A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475273A1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475230A1 Cytochrome p450 protein
08/14/2003CA2475211A1 Lyophilised preparation comprising immunocytokines
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2475066A1 Rhamnose binding protein
08/14/2003CA2475055A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003CA2474919A1 Formulation comprising bioactive agents and method of using same
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003CA2474652A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003CA2474431A1 Method of treating and preventing bone loss
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474203A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003CA2474145A1 Bacteriophage lysin
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473706A1 Heterocyclic compounds having elastase-inhibitory activity and intermediates thereof
08/14/2003CA2473212A1 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2472249A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003CA2471586A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003CA2471207A1 Method of inhibiting pathogenicity of infectious agents
08/14/2003CA2469748A1 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003CA2467893A1 Modified antigen-presenting cells
08/14/2003CA2466294A1 Hexa-, hepta-, and octapeptides having antiangiogenic activity
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003CA2463478A1 Methods for screening osteogenic compounds
08/13/2003EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
08/13/2003EP1335021A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
08/13/2003EP1335018A1 Sericin-containing material, process for producing the same and method of using the same
08/13/2003EP1334982A2 Solubilized complement receptor type 1 in crystal form
08/13/2003EP1334730A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/13/2003EP1334729A1 Therapeutic use of non-neurotoxic clostridium botulinum toxin type C2
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334196A2 Genomic fragment of streptococcus suis and clinical uses thereof
08/13/2003EP1334195A2 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334189A2 Molecules involved in the regulation of insulin resistance syndrome (irs)
08/13/2003EP1334188A2 Cd19-specific redirected immune cells
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334180A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334128A2 New multimeric interferon beta polypeptides
08/13/2003EP1334127A1 Single-chain multimeric polypeptides
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334124A2 Diastereomeric peptides and pharmaceutical compositions comprising them
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334120A2 Modified clostridial neurotoxins with altered biological persistence
08/13/2003EP1334119A2 Compositions and methods for modulating rsv infection and immunity
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
08/13/2003EP1333880A1 Transdermal drug delivery devices having coated microprotrusions
08/13/2003EP1333863A2 Vector system for transducing th positive neurons
1 ... 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 ... 3163